Richard de Bodo


Richard de Bodo is lead trial counsel in high-stakes, cutting-edge patent and trade secret cases for many of the world’s leading pharmaceutical, life sciences, and technology companies. Rich has an outstanding track record litigating and trying Hatch-Waxman cases and cases relating to biologic drugs, biosimilars, biotechnology, and medical devices. He has won significant victories in federal and state courts, arbitrations, the International Trade Commission (ITC), the US Patent Office, and other forums for companies seeking to protect US and international markets for their products or seeking to launch new products and overcome barriers to entry. Rich has experience counseling companies seeking to launch biosimilars in the US under the Biologics Price Competition and Innovation Act (BPCIA) and representing them in litigation, negotiations, and US Patent Office proceedings. He serves as the practice leader of Morgan Lewis’s life sciences intellectual property practice.